Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Biomarkers of ANTidepressant RESponse and Development Risk of Bipolar Disorder

NCT05568823 is registered in ClinicalTrials.gov with Assistance Publique Hopitaux De Marseille as lead sponsor.

NCT NCT05568823
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05568823 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Biomarkers of ANTidepressant RESponse and Development Risk of Bipolar Disorder
Lead sponsor
Assistance Publique Hopitaux De Marseille
Phase
Not applicable
Overall status
Unknown status
Start date
November 1, 2022
Completion date
January 2, 2025
Enrollment
244 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar disorder, depression, bipolar, major depressive disorder